Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GA.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HZ.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HZ.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.69EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.98EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.98EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.71EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.71EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2 (Omicron)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2 (Omicron)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used